JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB141069

3-Aminobenzamide (3-AB), PARP inhibitor

Be the first to review this product! Submit a review

|

(0 Publication)

MW 136.15 Da, Purity >99%. Poly(ADP-ribose) polymerase (PARP) inhibitor (Ki = 1.8 μM). Displays various biological actions including stimulation of angiogenesis. Additionally displays neuroprotective, anti-necrotic effects and shows free-radical scavenging ability.

View Alternative Names

(R)-limonene 6-monooxygenase, (S)-limonene 6-monooxygenase, (S)-limonene 7-monooxygenase, ADP ribosyltransferase, ADP ribosyltransferase (NAD+; poly (ADP ribose) polymerase), ADP ribosyltransferase NAD(+), ADP-ribosyltransferase diphtheria toxin-like 1, ADPRT, ADPRT 1, ARTD1, CP2C9_HUMAN, CPC9, CYP2C, CYP2C10, CYPIIC9, Cytochrome P-450MP, Cytochrome P450 2C9, Cytochrome P450 MP-4, Cytochrome P450 MP-8, Cytochrome P450 PB-1, Cytochrome P450, family 2, subfamily C, polypeptide 9, MGC149605, MGC88320, Microsomal monooxygenase, NAD(+) ADP-ribosyltransferase 1, OTTHUMP00000020135, P450 MP, P450 PB 1, P450IIC9, PARP, PARP1_HUMAN, PPOL, Poly (ADP ribose) synthetase, Poly (ADP-ribose) polymerase 1, Poly [ADP-ribose] polymerase 1, Poly(ADP ribose) polymerase, Poly(ADP-ribosyl)transferase, Poly[ADP ribose] synthetase 1, Poly[ADP-ribose] synthase 1, S-mephenytoin 4-hydroxylase, Xenobiotic monooxygenase, cytochrome P-450 S-mephenytoin 4-hydroxylase, flavoprotein-linked monooxygenase, msPARP, pADPRT-1, poly (ADP ribose) polymerase family, member 1, sPARP 1

1 Images
Chemical Structure - 3-Aminobenzamide (3-AB), PARP inhibitor (AB141069)
  • Chemical Structure

Lab

Chemical Structure - 3-Aminobenzamide (3-AB), PARP inhibitor (AB141069)

2D chemical structure image of ab141069, 3-Aminobenzamide (3-AB), PARP inhibitor

Key facts

CAS number

3544-24-9

Purity

>99%

Form

Solid

form

Molecular weight

136.15 Da

Molecular formula

C<sub>7</sub>H<sub>8</sub>N<sub>2</sub>O

PubChem

1645

Nature

Synthetic

Solubility

Soluble in water to 100 mM

Biochemical name

3-Aminobenzamide

Biological description

Poly(ADP-ribose) polymerase (PARP) inhibitor (Ki = 1.8 μM). Displays various biological actions including stimulation of angiogenesis. Additionally displays neuroprotective, anti-necrotic effects and shows free-radical scavenging ability.

Canonical smiles

C1=CC(=CC(=C1)N)C(=O)N

InChi

InChI=1S/C7H8N2O/c8-6-3-1-2-5(4-6)7(9)10/h1-4H,8H2,(H2,9,10)

InChiKey

GSCPDZHWVNUUFI-UHFFFAOYSA-N

IUPAC Name

3-aminobenzamide

style
left-column
style
left-column
style
left-column

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
Ambient
Appropriate long-term storage conditions
Ambient
Storage information
The product can be stored for up to 12 months
style
left-column

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

PARP1 also known as Poly (ADP-ribose) polymerase 1 is a protein with a molecular mass of approximately 113 kDa. This enzyme plays a mechanical role in the detection and repair of DNA damage through its ability to transfer ADP-ribose units onto acceptor proteins. It is expressed broadly in the nucleus of many cell types especially in tissues with high cellular turnover such as the bone marrow and intestinal epithelium. PARP1 is recognized for its interaction with NAD+ during DNA repair and is considered an important element in maintaining genomic stability.
Biological function summary

This protein contributes to DNA repair pathways by sensing DNA strand breaks and recruiting repair enzymes. PARP1 operates as part of a repair complex that initiates the base excision repair process. It facilitates the binding of repair proteins like XRCC1 to damaged DNA sites promoting efficient repair. PARP inhibitors named after their ability to block PARP1 activity are a focus of significant research interest. These include compounds such as 2-aminobenzamide 3-aminobenzamide and other variants marketed for their therapeutic potential.

Pathways

PARP1 functions prominently within the base excision repair (BER) and homologous recombination repair pathways. It interacts with proteins like DNA ligase III and DNA polymerase beta which are integral to BER. Additionally its role in the homologous recombination pathway connects it to proteins such as RAD51. These pathways are important for maintaining cellular integrity and preventing mutations making PARP1 a central player in the cell's defensive mechanisms against genomic instability.

PARP1 is heavily implicated in cancer especially breast and ovarian cancers. Both conditions often involve deficiencies in the BRCA1 and BRCA2 proteins. The dependency of cancer cells with BRCA mutations on PARP1 for DNA repair makes PARP inhibitors highly effective in treating these cancers. Additionally PARP1's involvement in apoptosis and inflammation ties it to neurodegenerative disorders like Parkinson's disease where disrupted DNA repair processes contribute to neuronal death. Effective targeting of PARP1 through pharmacological agents like those in the PARP inhibitor market shows promise in therapeutic strategies for these conditions.
style
left-column
style
left-column

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:
style
left-column
style
left-column

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions
style
left-column
style
right-column
style
bg-slate-100

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com